Skip to main content

Drugs in Neuroendocrinology

  • Chapter
Neurological Disorders

Abstract

Corticosteroids reduce antibody formation, and have an anti-inflammatory effect. The main use of these drugs in neurology is to suppress disease processes. Although corticosteroids are widely used in many different neurological disorders, their value is sometimes uncertain. The main indications are set out in Table 11.1.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Basten A, Pollard JD, Stewart GJ, Frith JA, McLeod JG, Walsh JC, Garrick R, van der Brink CM (1980) Transfer factor in treatment of multiple sclerosis. Lancet II: 931–934

    Article  Google Scholar 

  • Dowling PC, Bosch W, Cook SD (1980) Possible beneficial effect of high-dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis. Neurology (Minneap) 30: 33–36

    CAS  Google Scholar 

  • Miller H, Newell DJ, Ridley A (1961) Multiple sclerosis: treatment of acute exacerbations with corticotrophin (ACTH). Lancet II: 1120–1122

    Article  Google Scholar 

  • Miller JHD, Vas CJ, Naronha MJ, Liversedge LA, Rawson MD (1967) Long-term treatment of multiple sclerosis with corticotrophin. Lancet II: 429–431

    Article  Google Scholar 

  • Rawson MD, Liversedge LA, Goldfarb G (1966) Treatment of acute retrobular neuritis with corticotrophin. Lancet II: 1044–1046

    Article  Google Scholar 

  • Rawson MD, Liversedge LA (1969) Treatment of retrobulbar neuritis with corticotrophin. Lancet II: 222

    Article  Google Scholar 

  • Rosen A, Barsoum AH (1979) Failure of chronic dorsal column stimulation in multiple sclerosis. Ann Neurol 6: 66–67

    Article  PubMed  CAS  Google Scholar 

  • Saul TG, Ducker TB, Salcman M, Carro E (1981) Steroids in severe head injury: a prospective randomized clinical trial. J Neurosurg 54: 596–600

    Article  PubMed  CAS  Google Scholar 

  • Suloff MH, Ragatz RE (1982) Hyperbaric oxygenation for the treatment of acute cerebral edema. Neurosurgery 10: 29–38

    Article  Google Scholar 

  • Tourtelotte WW, Baumhefner RW, Potvin AR, Ma BI, Potrin JH, Mendez M, Syndulko K (1980) Multiple sclerosis de novo CNS IgG synthesis: effect of ACTH and corticosteroids. Neurology (Minneap) 30: 1155–1162

    Google Scholar 

  • Wiles CW (1982) Steroids in neurology. Br J Hosp Med 28: 308–322

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Parkes, J.D., Jenner, P., Rushton, D.N., Marsden, C.D. (1987). Drugs in Neuroendocrinology. In: Neurological Disorders. Treatment in Clinical Medicine. Springer, London. https://doi.org/10.1007/978-1-4471-3140-3_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3140-3_11

  • Publisher Name: Springer, London

  • Print ISBN: 978-3-540-17013-6

  • Online ISBN: 978-1-4471-3140-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics